WaveMan · Form 4
Tak Paul Peter insider trades
> Search tickers & screens ⌘K
LIVE

Tak Paul Peter insider trades

Tak Paul Peter has filed 18 Form 4s with the SEC that we hold, all for Candel Therapeutics, Inc. (CADL), as Chief Executive Officer, Director. Across all of them we count 3 purchases worth $230.0K and 9 sales worth $4.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($3.2M). The largest single trade was a sale of 220,866 shares of Candel Therapeutics, Inc. worth $2.5M, dated 2026-09-10. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-08-02 and the latest 2026-09-11.

Candel Therapeutics, Inc. (CADL)

Chief Executive Officer, Director · 18 filings · 12 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-07-29P, purchase reported on Form 425,000$200.0K2021-08-02
2022-12-08P, purchase reported on Form 43,050$5.2K2022-12-12
2022-12-09P, purchase reported on Form 412,935$24.8K2022-12-12
2024-07-11S, sale reported on Form 420,293$121.1K2024-07-15
2024-07-17S, sale reported on Form 422,528$145.8K2024-07-19
2024-11-29S, sale reported on Form 448,847$222.7K2024-12-03
2025-01-08S, sale reported on Form 421,172$174.0K2025-01-10
2025-01-15S, sale reported on Form 421,704$156.9K2025-01-17
2025-03-18S, sale reported on Form 425,772$226.0K2025-03-20
2025-03-19S, sale reported on Form 4400$3.6K2025-03-20
2026-09-10S, sale reported on Form 4220,866$2.5M2026-09-11
2026-09-11S, sale reported on Form 459,379$620.9K2026-09-11
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1873905) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms